NANOTRIAC
associated with 2 other trademarks
Pharmaceutical agents and preparations affecting macular degeneration, solid tumors, hematologic malignancies, ocular disorders, angiogenesis, arthrit...

Words that describe this trademark:

hematologic malignancies  macular degeneration  solid tumors  agents  tumors  pharmaceutical  affecting  preparations  malignancies  degeneration 

Serial Number:

86187328

Mark:

NANOTRIAC

Status:

Abandoned-No Statement of Use filed

Status Date:

04-09-2018

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceutical agents and preparations affecting macular degeneration, solid tumors, hematologic malignancies, ocular disorders, angiogenesis, arthritis, dermatology, digestive organs, metabolism, peripheral nervous system, sensory organs, central nervous system, hormonal disorders, diabetes, eye diseases and conditions, heart disorders, joint disease, cancer and the prevention and treatment of cancer, hyperthyroidism, Alzheimer's disease, respiratory diseases, chemotherapy and radioactive in vivo diagnostic or therapeutic use; radioactive pharmaceutical preparations for use in vivo diagnostic use; appetite suppressants; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based injectable, eye drop or oral delivery tablets or capsules for the continuous release of a wide variety of therapeutic agents; pharmaceutical skin lotion, cream, ointment, and skin patch Drug delivery systems consisting of polymer-based injectable, eye drop or oral delivery devices for the continuous release of a wide variety of therapeutic agents

Mark Description:

N/A

Class:

Surgical

Type of Mark:

Trademark

Published for Opposition Date:

01-06-2015

Mark Drawing Status:

Standart Character Mark

Abandon Date:

04-09-2018

Business Name:

SCHMEISER OLSEN & WATTS LLP

Correspondent Name:

Recent Trademark filings by this company